On June 20, eight new health startups are launching, thanks to backing from Rock Health, a new seed accelerator aiming to promote health-related mobile and web startups.
Based in San Francisco, Rock Health reviewed applications from health startups, and selected 10 new companies for a grant, office space in San Francisco, as well as branding, medical, and legal support, along with mentoring from industry experts.
Mentors include Path CEO and early member of the Facebook team Dave Morin, cofounder of RedOctane Charles Huang, and former FDA deputy commissioner Scott Gottlieb. The program's advisors include Twitter VP of engineering Michael Abbott, cofounder of 23andMe Linda Avey, and founder and CEO of HealthTap and former founder and CEO of Wellsphere Ron Gutman. Rock Health has also partnered with the Mayo Clinic, Harvard Medical School, and Cincinnati Children's Hospital.
Other companies working as purpose-focused startup accelerators include Greenstar, which covers green technology, and Imagine K12, which focuses on education.
Here are the eight new startups backed by Rock Health:
BrainBot is technology designed by Harvard and MIT researchers that aims to improve mental performance, from stress management skills to enhanced mental focus.
CellScope builds systems for at-home disease diagnosis using smartphone cameras.
Genomera enables users to operate open health studies.
HealthInReach is a Groupon-style site offering group discount rates for doctors and dentists.
Omada Health is a social media site focused on clinical treatments of disease.
Pipette allows doctors to monitor and educate patients throughout the course of their care using smartphones and tablets.
Skimble offers health and fitness apps geared to get you motivated and active. Workout Trainer (for iPhone/iPad) provides multimedia workouts lead by trainers, and GPS Sports Tracker (for iPhone and Android) tracks some 45 different activities.
WeSprout is a social networking site that helps busy parents connect while also providing resources, data, and advice.
Join our new commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies